IP Giveaway Threatens The Future Of Pharma The apparently widespread support for waiving patent protection for Covid-19 vaccines is symptomatic of a larger problem - namely a lack of fundamental understanding, among the public in general and legislators in particular, of the nature of drug development and why IP protection is so important.